The Ground Truth

Myalgic Encephalomyelitis (ME) is a serious, chronic, multi-system disease that affects an estimated 15–30 million people worldwide. In the United Kingdom alone, approximately 250,000 people live with this condition. Among them, around 25% are housebound or bedbound — unable to leave their homes, and in many cases unable to leave their beds.

ME is classified by the World Health Organization as a neurological disease (ICD-10 G93.3). It is characterised by profound impairment of energy metabolism, dysfunction of the autonomic nervous system, immune dysregulation, and neuroinflammation. These are not psychological phenomena. They are measurable, reproducible biological abnormalities.

The hallmark feature of ME is post-exertional malaise (PEM): a delayed and disproportionate worsening of symptoms following physical, cognitive, or emotional exertion. Unlike normal fatigue, PEM can be triggered by activities as minimal as showering, speaking, or sitting upright — and its effects can persist for days, weeks, or permanently.

In healthy individuals, exertion leads to temporary fatigue followed by recovery. In ME, this process is fundamentally broken. Exertion beyond the body's drastically reduced capacity does not lead to adaptation or improvement — it causes physiological harm.

Research has demonstrated that people with ME exhibit abnormal responses to repeated exercise testing. Where healthy controls improve on a second day of testing, ME patients show marked decline in cardiopulmonary function, oxygen utilisation, and cognitive performance. This is objective, reproducible evidence of biological dysfunction.

The implications are profound: treatments that encourage increased activity — such as Graded Exercise Therapy (GET) — are not merely ineffective. They are harmful. Patient surveys consistently report that GET is the intervention most likely to make patients worse, not better.

One of the most damaging aspects of ME is its invisibility. On a “good day” — a day when symptoms are less severe — a person with ME may appear well. They may be able to have a conversation, sit upright, or even leave the house briefly.

What observers do not see is the cost. That brief period of activity may require days of rest beforehand and days or weeks of recovery afterward. The person you see walking to a medical appointment may collapse upon returning home. The patient who seems “fine” in a clinic may be bedbound for weeks following the visit.

This creates a systematic bias against patients. Clinicians, assessors, family members, and the public routinely misjudge the severity of ME because they only witness moments of relative functionality. The disease is experienced in private, in darkness, in silence — and its reality is rarely witnessed by those making judgements about it.

For this reason, standard clinical observations and brief assessments are fundamentally inadequate for understanding ME. What a patient can do in a ten-minute appointment bears no relation to what they can sustain over hours, days, or weeks.

For decades, UK medical guidance was dominated by a psychological model of ME. The condition was framed as a problem of “illness beliefs” and “deconditioning” — requiring cognitive behavioural therapy and graded exercise to overcome. This approach was based on the PACE trial, which has since been widely discredited due to methodological flaws, outcome switching, and failure to use objective measures.

In 2021, the National Institute for Health and Care Excellence (NICE) published new guidelines explicitly rejecting these treatments. NICE found that GET should not be offered to people with ME, and that CBT should not be offered as a treatment for ME itself. The evidence base for the psychological model had collapsed.

Yet implementation has been slow and uneven. Many clinical services continue to offer graded activity programmes under different names. Welfare assessments still fail to account for post-exertional deterioration. Educational institutions still teach outdated models. The gap between official guidance and lived reality remains vast.

Beyond treatment, the systems failures extend to research funding, medical education, welfare assessment, and public understanding — each compounding the harm caused by misunderstanding.

The question of ME is no longer simply medical. It is a matter of public truth. For too long, institutional assumptions have overridden scientific evidence. Patients have been harmed not by the disease alone, but by the systems that were supposed to help them.

The COVID-19 pandemic has made this issue more urgent. Long COVID shares significant overlap with ME, and millions of new patients are now experiencing the same dismissal, the same failed treatments, and the same systematic disbelief that ME patients have faced for decades.

This is a moment of reckoning. The old assumptions have been exposed. The evidence is clear. What remains is the question of whether institutions will correct course — or whether they will continue to defend positions that have caused widespread harm.